MorphoSys AG
Antagonists of IL17C for the treatment of inflammatory disorders
Last updated:
Abstract:
The present invention provides antagonists of IL17C for use in the treatment of an inflammatory disorder.
Status:
Grant
Type:
Utility
Filling date:
8 Nov 2018
Issue date:
27 Oct 2020